U.S. Capital Markets Stock News

NYSE:HLIO
NYSE:HLIOMachinery

Helios Technologies (HLIO) Valuation Check After Recent Share Price Softness

Context for Helios Technologies after recent performance Helios Technologies (HLIO) has drawn renewed investor interest after a recent period where the stock showed mixed moves, with a 2.3% decline over the past week and a 2.2% decline over the past month. See our latest analysis for Helios Technologies. Despite the recent soft patch in the share price, with a 30 day share price return of a 2.18% decline, momentum over a longer window still reflects a 22.17% year to date share price gain and...
NYSE:GVA
NYSE:GVAConstruction

A Look At Granite Construction (GVA) Valuation As Raised 2026 Guidance Follows Strong Q1 Results

Granite Construction (GVA) is back in focus after Q1 2026 results showed stronger than expected revenue, a higher full year revenue outlook to US$5.2b to US$5.4b, and record backlog supported by acquisitions. See our latest analysis for Granite Construction. The stronger Q1 2026 update appears to have fed into the share price, with Granite Construction’s 7 day share price return of 13.01% and 30 day return of 13.98% adding to a 1 year total shareholder return of 72.64%. This suggests momentum...
NYSE:CALY
NYSE:CALYLeisure

Is It Too Late To Reassess Callaway Golf (CALY) After Its Recent Share Price Surge

If you are wondering whether Callaway Golf at around US$15.16 is still reasonably priced after its recent run, the valuation story is the key place to focus. The stock has seen sharp moves, with a 29.4% return year to date and 121.3% over the last year, set against a 32.1% decline over three years and a 51.3% decline over five years. These swings have kept Callaway Golf on many watchlists, as investors weigh shorter term momentum of 9.7% over the last 30 days against a 1% decline over the...
NasdaqGS:MEDP
NasdaqGS:MEDPLife Sciences

Raised 2026 Guidance And Leadership Change Might Change The Case For Investing In Medpace (MEDP)

In April 2026, Medpace Holdings reported first-quarter 2026 results showing sales of US$706.6 million and net income of US$123.87 million, with both basic and diluted earnings per share rising year over year, and issued full-year 2026 guidance for revenue of US$2.76–2.86 billion and GAAP net income of US$487.0–511.0 million alongside President Jesse Geiger’s planned retirement. An interesting detail for investors is that Medpace’s full-year 2026 outlook assumes a 19–20% tax rate and US$27.5...
NYSE:PLGO
NYSE:PLGOInsurance

Fidelis Buyback And Bye Law Changes Reframe Capital Return Outlook

Fidelis Insurance Holdings (NYSE:FIHL) has entered into a major share repurchase agreement that ends founding shareholder CVC Falcon Holdings Limited's ownership stake. The company has also approved amendments to its Bye Laws at its latest annual meeting, signaling changes to its governance framework. These decisions mark a meaningful shift in ownership and corporate rules that is relevant for existing and prospective shareholders. Fidelis Insurance Holdings, a specialty insurance and...
NasdaqGS:INCY
NasdaqGS:INCYBiotechs

Is It Too Late To Consider Incyte (INCY) After A 55% One Year Rally?

If you are wondering whether Incyte's current share price still offers value or has already priced in recent enthusiasm, the next sections will walk through what the numbers actually say. Over the past year the stock has returned 55.0%, with shorter term moves of 2.4% over 7 days, 2.8% over 30 days and a year to date return of a 4.4% decline, which can change how the market views both its growth potential and its risks. Recent coverage has focused on Incyte's position in biotech and the...
NYSE:HUN
NYSE:HUNChemicals

Huntsman Q1 Loss Of US$0.30 Per Share Tests Bullish Margin Recovery Narratives

Huntsman (HUN) opened 2026 with Q1 revenue of US$1.4 billion and a basic EPS loss of US$0.30, while the trailing twelve months show revenue of US$5.7 billion and a basic EPS loss of US$1.87. Over recent quarters, revenue has ranged between US$1.4 billion and US$1.5 billion, with quarterly basic EPS losses stretching from roughly US$0.02 to US$0.92. Investors are therefore looking at a business that is still working through margin pressure rather than expanding profitability. See our full...
NasdaqGS:TER
NasdaqGS:TERSemiconductor

Is It Too Late To Consider Buying Teradyne (TER) After Its 356.9% One-Year Surge?

Wondering if Teradyne at US$345.42 is priced for perfection or still offers value? This article breaks down what the current market price might be implying. The stock has seen sharp moves, with a 17.4% decline over the last 7 days, an 11.6% gain over 30 days, and returns of 66.4% year to date and 356.9% over the past year. Recent coverage of Teradyne has focused on its role in semiconductors and automation, and how investor interest in these themes has lined up with the share price moves...
NasdaqCM:NUTX
NasdaqCM:NUTXHealthcare

A Look At Nutex Health (NUTX) Valuation After Q1 2026 Earnings Surge And Expansion Plans

Nutex Health (NUTX) is back on investors’ radar after Q1 2026 results showed net income more than doubling year over year, stronger EPS, and continued hospital expansion plans supported by its existing arbitration driven model. See our latest analysis for Nutex Health. That earnings surprise and expansion pipeline have coincided with a sharp rebound in the shares, with a 1 day share price return of 17.1%, 7 day share price return of 28.9% and 30 day share price return of 41.8%. The 1 year...
NasdaqGS:MXL
NasdaqGS:MXLSemiconductor

MaxLinear’s Washington TIA Targets AI Data Center Growth And Risks

MaxLinear (NasdaqGS:MXL) introduced its Washington 200G per lane optical transimpedance amplifier for 1.6T AI data center interconnects. Samples of the new TIA are currently available to customers, with mass production targeted for the second half of 2026. The launch comes as the company reports upgraded sales targets and momentum in its optical business. For investors tracking AI infrastructure, this move places MaxLinear closer to the core of next generation data center build outs. The...
NYSE:FDS
NYSE:FDSCapital Markets

Is FactSet Research Systems (FDS) Now Pricing In Too Much Pessimism After 1-Year Slump

Wondering whether FactSet Research Systems at around US$227.58 still reflects its true worth, or if the market has moved ahead of the fundamentals. The stock has risen 1.5% over the last 7 days and 1.2% over the last 30 days, although year to date it is down 20.1% and the 1 year return sits at a 46.9% loss. These moves come as investors reassess established financial data and analytics providers. FactSet Research Systems is often mentioned in discussions around long term demand for market...
NasdaqGS:WDC
NasdaqGS:WDCTech

Western Digital (WDC) One Off Gain Lifts Margins And Tests Bullish Earnings Narratives

Western Digital (WDC) has put up another big quarter, with Q2 2026 revenue at US$3.0b and basic EPS of US$5.27, backed by trailing twelve month revenue of US$10.7b and EPS of US$11.40 that reflect a very large year over year earnings swing. Over recent quarters, the company has seen revenue move from US$2.2b in Q1 2025 to US$3.0b in Q2 2026, while basic EPS has shifted from US$0.43 to US$5.27. This sets up a story where higher reported profitability, supported by a 36.8% trailing net margin...
NasdaqGM:ODD
NasdaqGM:ODDPersonal Products

Oddity Tech (ODD) Is Down 8.5% After Class Action Over Ad Cost Disclosures - What's Changed

The Gross Law Firm recently announced a class action lawsuit on behalf of Oddity Tech shareholders, alleging the company made materially false and misleading statements about digital advertising costs after an algorithm change by its largest advertising partner increased customer acquisition costs and hurt its business outlook. This legal challenge raises fresh questions about how dependent Oddity’s business model is on a single digital ad ecosystem and the transparency of its cost...
NYSE:RVLV
NYSE:RVLVSpecialty Retail

Is Revolve Group (RVLV) Fairly Priced After Its 12.5% Monthly Share Price Jump

Wondering if Revolve Group at around US$24.98 is giving you value or just volatility? This article breaks down what the current price might really represent. The stock has a mixed recent record, with a 12.5% gain over 30 days, a 6.9% pullback over the last week, a 27.9% return over 1 year and a 57.0% decline over 5 years. Recent coverage has focused on how Revolve Group fits within the broader U.S. retail space and how investors are reacting to changing consumer preferences and online...
NasdaqGS:TXG
NasdaqGS:TXGLife Sciences

Does Atera’s New Spatial Biology Platform Change The Bull Case For 10x Genomics (TXG)?

10x Genomics recently launched Atera, an in situ spatial biology platform for whole-transcriptome, single-cell–sensitivity analysis across fresh-frozen and FFPE tissues, unveiling early data and opening pre-orders at the AACR 2026 meeting. Atera’s scale, early adoption by groups like Macrogen and the Human Cell Atlas, and integrated cloud analytics could materially expand 10x’s role in high-throughput spatial and AI-driven research workflows. We’ll now examine how Atera’s...
NYSE:HASI
NYSE:HASIDiversified Financial

Is It Too Late To Consider HA Sustainable Infrastructure Capital (HASI) After Its 75% One-Year Rally?

If you are wondering whether HA Sustainable Infrastructure Capital is attractively priced or starting to look stretched, the recent share price moves give a useful starting clue. The stock last closed at US$42.53, with returns of 1.9% over 7 days, 13.2% over 30 days, 33.7% year to date, 75.1% over 1 year, 93.6% over 3 years and 14.0% over 5 years. These moves may have shifted how the market views its potential and risk. Recent coverage has focused on HA Sustainable Infrastructure Capital...
NYSE:SON
NYSE:SONPackaging

Sonoco Products Trust Recognition Meets Discounted Valuation And Mixed Momentum

Sonoco Products (NYSE:SON) has been named to Newsweek’s list of America’s Most Trustworthy Companies for 2026. The recognition reflects external assessment of the company’s reputation, governance, and stakeholder trust. This marks a fresh development for Sonoco Products, separate from recent discussions focused on financials and valuation. For investors tracking Sonoco Products at a share price of $50.06, this trust focused recognition adds a different angle to the story that has recently...
NYSE:AEO
NYSE:AEOSpecialty Retail

Is American Eagle Outfitters (AEO) Offering Value After Recent Share Price Pullback?

If you are wondering whether American Eagle Outfitters at around US$16.94 is offering good value today, the key is to separate short term noise from what the fundamentals suggest the shares might be worth. The stock has seen a mixed return profile, with a 5.4% decline over the last 7 days and a 2.2% decline over 30 days, set against a 35.7% fall year to date, a 57.6% gain over the past year, and 39.6% over three years, while the five year return sits at a 47.0% loss. Recent coverage has...
NasdaqGS:MPWR
NasdaqGS:MPWRSemiconductor

Monolithic Power Systems (MPWR) Q1 2026 Margin Drop Tests Bullish AI Growth Narrative

Monolithic Power Systems (MPWR) has opened Q1 2026 with revenue of US$804.2 million and basic EPS of US$3.94, setting a clear marker for how the year is starting after a strong run of quarterly reports. Over recent quarters, the company has seen revenue move from US$637.6 million in Q1 2025 to US$751.2 million in Q4 2025 and EPS shift from US$2.80 to US$3.62, giving investors a concrete view of how the top and bottom lines have tracked into this latest print. With trailing net profit margin...